Rapid method for generating safe live attenuated vaccines for viral disease prevention
Date: 7.6.2019
Summary:
A Singapore-based institute has developed a rapid and reliable method for generating safe live attenuated vaccines (LAVs). Traditionally, attenuated strains are developed through serial passage in cell lines or in animals. This chance discovery can take years with no guarantee of success. With this new technology, it takes just 10 weeks for generation of a suitable LAV candidate.
The institute seeks to partner SMEs, MNEs and healthcare organisations via license or research agreements.
Reference: TOSG20190114002
Country: Singapore
Submitted: 7. 6. 2019
Keywords
Technology: Human vaccines
Market: Drug delivery and other equipment
NACE: Manufacture of basic pharmaceutical products; Manufacture of pharmaceutical preparations
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
